CSTS Health Care
Toronto
About CSTS Health Care
CSTS Health Care (www.cstshealthcare.com) is a Toronto based biotech founded to create efficacious cancer therapies free from toxic side effects. We are dedicated to improving patient survival and quality of life through our new class of precision oncology agents called Platelet Facilitated Drugs (PFDs). Our novel drug technology, Cytesia, allows delivery of precision drug combinations directly to tumour sites with minimal toxicities, and our proprietary computational biology techniques integrate each patient’s molecular information into a high-fidelity cancer model, drawing upon insights from multiple branches of science and medicine, to provide a rich pipeline of next generation therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2018)
- Website: cstshealthcare.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Oncology
Social Profiles
Canonical: https://fsome.com/organization/csts-health-care-2951654 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.